As elsewhere in mainland Europe, the slow vaccine rollout means that the rebound in domestic activity is unlikely to get underway in earnest until Q3. Denmark is a noteworthy exception; its comparative success in containing the virus has allowed it to start to ease restrictions already. While the decision to discontinue use of the AstraZeneca jab means it may have to tread a bit more carefully from here, our 2021 GDP forecast is above the consensus. More generally, having experienced some of the smallest falls in output in Europe in 2020, GDP in Switzerland and the Nordics will get back to pre-virus levels in H2 2021 – about a year ahead of the euro-zone.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services